Matches in Wikidata for { <http://www.wikidata.org/entity/Q37762935> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q37762935 description "article científic" @default.
- Q37762935 description "article scientifique" @default.
- Q37762935 description "articolo scientifico" @default.
- Q37762935 description "artigo científico" @default.
- Q37762935 description "artículu científicu espublizáu en 2010" @default.
- Q37762935 description "bilimsel makale" @default.
- Q37762935 description "scientific article published on May 2010" @default.
- Q37762935 description "vedecký článok" @default.
- Q37762935 description "vetenskaplig artikel" @default.
- Q37762935 description "videnskabelig artikel" @default.
- Q37762935 description "vědecký článek" @default.
- Q37762935 description "wetenschappelijk artikel" @default.
- Q37762935 description "wissenschaftlicher Artikel" @default.
- Q37762935 description "наукова стаття, опублікована в травні 2010" @default.
- Q37762935 description "научни чланак" @default.
- Q37762935 description "مقالة علمية نشرت في مايو 2010" @default.
- Q37762935 name "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 name "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 name "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 type Item @default.
- Q37762935 label "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 label "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 label "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 prefLabel "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 prefLabel "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 prefLabel "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 P1433 Q37762935-61BF3ABC-F56E-4425-AAE3-0453A4BD85EC @default.
- Q37762935 P1476 Q37762935-0155CF74-FD54-4B65-A161-9AD7E1EB9914 @default.
- Q37762935 P2093 Q37762935-5F5DC1DF-A7F6-442A-9D9F-B94809E1CEBF @default.
- Q37762935 P2093 Q37762935-9B4E42B3-8FDF-49EB-AD6F-103836EC8054 @default.
- Q37762935 P2093 Q37762935-BEDB6AE8-0BF5-4AA7-B588-F41304165EE4 @default.
- Q37762935 P2093 Q37762935-C9AB1819-332D-42B7-A52F-F260F98684EA @default.
- Q37762935 P304 Q37762935-BA826945-6714-4930-9ABD-28932C5F8B11 @default.
- Q37762935 P31 Q37762935-33369C4F-4063-4856-B75E-2FA81E6BD0DB @default.
- Q37762935 P31 Q37762935-c58a7ed3-cef6-4335-939a-e301a366788e @default.
- Q37762935 P356 Q37762935-3807D295-50B9-42C7-AEA3-1853FE4DB77A @default.
- Q37762935 P433 Q37762935-1D14FD7F-9791-447D-8C6C-DC74AF29CB5B @default.
- Q37762935 P478 Q37762935-54F9C1EB-930C-4353-B323-4F1C6ABAA380 @default.
- Q37762935 P577 Q37762935-086BB5F6-6884-4961-B28C-2E83C46453DA @default.
- Q37762935 P698 Q37762935-E09B54BD-853A-4F79-8A5F-8228ADC57684 @default.
- Q37762935 P921 Q37762935-5607FCD5-6F70-4265-B5D0-BB5EB81D756A @default.
- Q37762935 P921 Q37762935-82E12BF3-B395-4F50-9E76-CBAA78D92ADD @default.
- Q37762935 P921 Q37762935-CF22D9E9-37D3-4042-A326-5D616A1AF7C2 @default.
- Q37762935 P356 PPO.0B013E3181DBEBF9 @default.
- Q37762935 P698 20526094 @default.
- Q37762935 P1433 Q2589130 @default.
- Q37762935 P1476 "Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside" @default.
- Q37762935 P2093 "Daniel S W Tan" @default.
- Q37762935 P2093 "David Olmos" @default.
- Q37762935 P2093 "Ian R Judson" @default.
- Q37762935 P2093 "Robin L Jones" @default.
- Q37762935 P304 "183-194" @default.
- Q37762935 P31 Q13442814 @default.
- Q37762935 P31 Q7318358 @default.
- Q37762935 P356 "10.1097/PPO.0B013E3181DBEBF9" @default.
- Q37762935 P433 "3" @default.
- Q37762935 P478 "16" @default.
- Q37762935 P577 "2010-05-01T00:00:00Z" @default.
- Q37762935 P698 "20526094" @default.
- Q37762935 P921 Q422248 @default.
- Q37762935 P921 Q7240673 @default.
- Q37762935 P921 Q79460 @default.